Literature DB >> 25131645

Declining trends in the proportion of non-viral sexually transmissible infections reported by STD clinics in the US, 2000-10.

Kwame Owusu-Edusei1, Bianca J Sayegh1, Alesia J Harvey1, Robert J Nelson1.   

Abstract

UNLABELLED: Background Recent budget shortfalls may have resulted in decreases in the number of sexually transmissible infections (STIs) reported from sexually transmitted disease clinics (STDCs) in the United States (US). The objective of this study was to examine the proportion of cases reported from STDCs for three non-viral STIs in the last decade.
METHODS: Data from the national surveillance database on primary and secondary (P&S) syphilis, gonorrhoea and chlamydia cases for 2000-10 were extracted. The percentage of cases reported by STDCs for the nation and for each of the 48 contiguous states were then computed. Finally, the χ(2) trend test for proportions was used to determine the annual average decrease/increase in the percentage of cases reported by STDCs for the nation and for each state.
RESULTS: RESULTS demonstrate that the average annual declines in the proportion of P&amp;S syphilis, gonorrhoea, and chlamydia cases reported from STDCs were 1.43% (P<0.01), 1.31% (P<0.01), and 0.31% (P<0.01), respectively. Additionally, most of the states with statistically significant trends (P<0.05) in the proportion of cases reported by STDCs had negative slopes: 86% (25/29) for P&amp;S syphilis, 89% (34/38) for gonorrhoea, and 63% (27/43) for chlamydia.
CONCLUSION: These results document the declining role of STDCs in STI prevention and control efforts in the US. Further studies are needed to assess the direct or indirect impact of the decline in the proportion of cases from STDCs on the overall STI control and prevention efforts in the US and its implications for the future.

Entities:  

Year:  2014        PMID: 25131645      PMCID: PMC6784842          DOI: 10.1071/SH14057

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  9 in total

1.  Privatization of STD services in Tacoma, Washington: a quality review.

Authors:  C Eubanks; W E Lafferty; A M Kimball; R MacCornack; W J Kassler
Journal:  Sex Transm Dis       Date:  1999-10       Impact factor: 2.830

2.  County-level sexually transmitted disease detection and control in Texas: do sexually transmitted diseases and family planning clinics matter?

Authors:  Kwame Owusu-Edusei; Sonal R Doshi
Journal:  Sex Transm Dis       Date:  2011-10       Impact factor: 2.830

3.  Assessing spatial gaps in sexually transmissible infection services and morbidity: an illustration with Texas county-level data from 2007.

Authors:  Kwame Owusu-Edusei; Sonal R Doshi
Journal:  Sex Health       Date:  2012-09       Impact factor: 2.706

4.  Improving clinical operations: can we and should we save our STD clinics?

Authors:  Matthew R Golden; Peter R Kerndt
Journal:  Sex Transm Dis       Date:  2010-04       Impact factor: 2.830

5.  STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians.

Authors:  Janet S St Lawrence; Daniel E Montaño; Danuta Kasprzyk; William R Phillips; Keira Armstrong; Jami S Leichliter
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

6.  The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.

Authors:  Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

Review 7.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

Review 8.  Sexually transmitted diseases and managed care: an inquiry and review of issues affecting service delivery.

Authors:  Terence Chorba; Delia Scholes; June Bluespruce; Belinda H Operskalski; Kathleen Irwin
Journal:  Am J Med Qual       Date:  2004 Jul-Aug       Impact factor: 1.852

9.  Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

Authors:  Hillard Weinstock; Stuart Berman; Willard Cates
Journal:  Perspect Sex Reprod Health       Date:  2004 Jan-Feb
  9 in total
  6 in total

1.  Medicaid Coverage of Sexually Transmitted Disease Service Visits.

Authors:  William S Pearson; Ian H Spicknall; Ryan Cramer; Wiley D Jenkins
Journal:  Am J Prev Med       Date:  2019-05-22       Impact factor: 5.043

2.  Differences in Treatment of Chlamydia trachomatis by Ambulatory Care Setting.

Authors:  William S Pearson; Thomas L Gift; Jami S Leichliter; Wiley D Jenkins
Journal:  J Community Health       Date:  2015-12

3.  The Spatial Association Between Federally Qualified Health Centers and County-Level Reported Sexually Transmitted Infections: A Spatial Regression Approach.

Authors:  Kwame Owusu-Edusei; Thomas L Gift; Jami S Leichliter; Raul A Romaguera
Journal:  Sex Transm Dis       Date:  2018-02       Impact factor: 2.830

4.  Examining Fluoroquinolone Claims Among Gonorrhea-Associated Prescription Drug Claims, 2000-2010.

Authors:  Kwame Owusu-Edusei; Danya S Carroll; Thomas L Gift
Journal:  Am J Prev Med       Date:  2015-07-16       Impact factor: 5.043

5.  Get In, Get Tested, Get Care: STD Services in Urban Urgent Care Centers.

Authors:  Samantha P Williams; Jennine Kinsey; Monique G Carry; Latasha Terry; Joy Wells; Karen Kroeger
Journal:  Sex Transm Dis       Date:  2019-10       Impact factor: 2.830

6.  The Program Cost of a Brief Video Intervention Shown in Sexually Transmitted Disease Clinic Waiting Rooms.

Authors:  Thomas L Gift; Lydia N OʼDonnell; Cornelis A Rietmeijer; Kevin C Malotte; Jeffrey D Klausner; Andrew D Margolis; Craig B Borkowf; Charlotte K Kent; Lee Warner
Journal:  Sex Transm Dis       Date:  2016-01       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.